SCHEMBL23946313

SCHEMBL23946313

c1ccc(-c2ncnc3c(-c4ccccc4)cccc23)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.56
LIMK1 P53667 3/20 0.49
JAK2 O60674 2/20 0.46
ENPP1 P22413 2/20 0.41
PLG P00747 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2C8 P10632 1/20 0.40
CYP2C9 P11712 1/20 0.40
DHODH Q02127 1/20 0.40
MAP4K4 O95819 1/20 0.39
CSF1R P07333 1/20 0.39
FGFR1 P11362 1/20 0.39
PDGFRA P16234 1/20 0.39
LTK P29376 1/20 0.39
KDR P35968 1/20 0.39
MAPK8 P45983 1/20 0.39
CSNK1A1 P48729 1/20 0.39
CDK5 Q00535 1/20 0.39
ACVR1 Q04771 1/20 0.39
TNK2 Q07912 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23946250 0.93 ADORA2A (0.53) ADORA2ALIMK1JAK2ENPP1PLG
SCHEMBL23946254 0.86 LIMK1 (0.44) ADORA2ALIMK1ENPP1MAPK8KDM4E
SCHEMBL23946298 0.86 ADORA2A (0.50) ADORA2ALIMK1JAK2MAPK8PIK3CD
SCHEMBL22373712 0.80 TDO2 (0.42) ADORA2ALIMK1JAK2PIK3CDPIK3CA
SCHEMBL28872929 0.80 ADORA2A (0.55) ADORA2ALIMK1JAK2CYP3A4CYP2C9
SCHEMBL30639391 0.80 LIMK1 (0.63) LIMK1PLGMAP4K4CSF1RFGFR1
SCHEMBL13313201 0.80 ADORA2A (0.55) ADORA2ALIMK1JAK2KDM4EALDH1A1
SCHEMBL13313198 0.77 ADORA2A (0.51) ADORA2AJAK2KDM4EALDH1A1GAA
SCHEMBL19024776 0.77 ADORA2A (0.44) ADORA2ALIMK1JAK2PLGCYP3A4
SCHEMBL19024600 0.77 LIMK1 (0.72) ADORA2ALIMK1JAK2ENPP1PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210328153-A1 ELECTROLUMINESCENT MATERIALS AND DEVICES Beijing Summer Sprout Technology Co., Ltd. (CN) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210328153-A1 ELECTROLUMINESCENT MATERIALS AND DEVICES IDO1, IDO2, AZI2 ADORA2A 333/4885LIMK1 1065/4885JAK2 1233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.